Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

remedyrepack inc. - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bryant ranch prepack - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

avera mckennan hospital - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

par pharmaceutical - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets, usp are indicated: - in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and - for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: -  patients with intestinal or urinary obstruction, -  patients with porphyria as sulfonamides have been reported to precipitate an acute attack, -  patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

blenheim pharmacal, inc. - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets, usp are indicated: - in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and - for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: -  patients with intestinal or urinary obstruction, -  patients with porphyria as sulfonamides have been reported to precipitate an acute attack, -  patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets, usp are indicated: - in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and - for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: -  patients with intestinal or urinary obstruction, -  patients with porphyria as sulfonamides have been reported to precipitate an acute attack, -  patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets are indicated: sulfasalazine tablets are contraindicated in: none reported.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

remedyrepack inc. - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

kaiser foundation hospitals - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

avpak - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets are indicated: - in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and - for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides or salicylates. none reported.